Carl R. Iberger
2021
In 2021, Carl R. Iberger earned a total compensation of $1.3M as Chief Financial Officer at Transgenomic, a 191% increase compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Option Awards | $905,832 |
| Salary | $250,000 |
| Other | $13,225 |
| Total | $1,259,057 |
Iberger received $905.8K in option awards, accounting for 72% of the total pay in 2021.
Iberger also received $90K in bonus, $250K in salary and $13.2K in other compensation.
Rankings
In 2021, Carl R. Iberger's compensation ranked 7,938th out of 12,415 executives tracked by ExecPay. In other words, Iberger earned more than 36.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,938 out of 12,415 | 36th |
Division Manufacturing | 3,507 out of 5,505 | 36th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 456 out of 801 | 43rd |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 125 out of 206 | 39th |
Industry Laboratory Analytical Instruments | 60 out of 90 | 33rd |
Source: SEC filing on April 28, 2022.
Iberger's colleagues
We found three more compensation records of executives who worked with Carl R. Iberger at Transgenomic in 2021.